Business

November 6, 2013

Pozen reports narrower loss in third quarter

Pozen reported early Wednesday a narrower loss in the third quarter thanks mainly to royalty payments from sales of Vimovo, an arthritis pain reliever licensed to AstraZeneca.

Related content

Comments

Videos

Editor's Choice Videos